Hematology
Rachel Sanborn, MD
Medical Director, Thoracic Oncology Program; Medical Director, Phase I Clinical Trials Program, Earle A. Chiles Research Institute, Providence Cancer Institute
Dr. Rachel E. Sanborn is a medical oncologist specializing in thoracic oncology at Providence Cancer Institute in Portland, Oregon. She serves as Medical Director of the Thoracic Oncology Program and Medical Director of the Phase I Clinical Trials Program at the Earle A. Chiles Research Institute. With over 25 years of experience, she focuses on lung cancer, including non-small cell lung cancer, small cell lung cancer, lung metastases, and rare thoracic malignancies such as mesothelioma, thymoma
25+
Years in Practice
Credentials
Board Certifications
- Medical Oncology (ABIM)
- Internal Medicine (ABIM)
Education & Training
- Oregon Health & Science University — Fellowship, Hematology/Medical Oncology
- University of Illinois at Chicago — Residency, Internal Medicine
- Oregon Health & Science University — M.D.
Peer Recognition
- Castle Connolly — Top Doctor
2022-2026 (5 years)
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Providence Portland Medical Center
- Providence Cancer Institute
Languages
English
Experience
25+ years in practice